Casper Marc N's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Sep 1, 2026
- Accession no.
- 0000097745-26-000167
- Filed
- Sep 1, 2026, 4:11 PM ET
- Trade date
- Aug 28, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Casper Marc NCIK 0001216055 | Director, Officer (Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | Common Stock | FTax withholdingDisposed | −724.766 | $622.18 | −$450,934.91 | 123,200.592 | Direct | |
| Aug 28, 2026 | Common Stock | FTax withholdingDisposed | −531.851 | $622.18 | −$330,907.06 | 122,668.741 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.